NEW YORK, Oct. 10 /PRNewswire/ -- Metastatic Breast Cancer Network
(MBCN) today announced that October 13, 2007, has been designated the first
Metastatic Breast Cancer Awareness Day by New York City Mayor Michael
Bloomberg. Metastatic Breast Cancer Awareness Day will be held in
conjunction with the MBCN's Metastatic Breast Cancer Conference targeted to
women in New York City living with MBC.
According to the New York State Cancer registry, last year, about 1,195
women died from breast cancer in New York City alone. Breast cancer deaths
are largely attributed to metastatic breast cancer (MBC). Nationwide, it is
estimated that there are 150,000 women living with MBC in the U.S.
The Metastatic Breast Cancer Conference will be held in conjunction
with NYU Cancer Institute and is supported by the Young Survival Coalition.
Conference subjects will include an update on treatments, including the
role of surgery and radiation in the management of MBC.
"It is important to recognize this significant, yet underserved patient
population and to provide the support, information and resources they need.
Because of patients' fears and the possibility of MBC, many don't
understand their risk of recurrence, which strikes some 30 percent of women
diagnosed with breast cancer," said Deborah Axelrod, MD, Associate
Professor of Surgery, New York University School of Medicine and a
Conference speaker. "Organizations like MBCN and events like Metastatic
Breast Cancer Awareness Day and the Metastatic Breast Cancer Conference
will go a long way towards putting a public face on the woman with
metastatic breast cancer, help ease the fears of all women who face the
possibility of recurrence, and, most importantly, inform these patients
that they have more options than ever before to manage their disease. We
hope the women of New York City with MBC will come out on October 13 to
learn about them."
Additional speakers will be Amy Tiersten, MD, Associate Professor of
Oncology at NYU; and Stella Lymberis, MD, of the Department of Radiation
Oncology, at NYU Medical Center.
MBCN seeks to raise awareness through the support of the community and
events that focus on MBC. According to Larry Norton, MD, Deputy
Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering
Cancer Center in New York City, "The MBCN has made significant strides
toward demystifying metastatic breast cancer and informing people of their
management options, realistic avenues of help and hope, and the new
opportunities afforded by advancing science. Information leads to knowledge
leads to rational action: that's the best antidote to fear."
"Living with [metastatic breast] cancer as a chronic illness is living
with uncertainty, but life is always uncertain," said Oni Faida Lampley,
author of the play Tough Titty and New York City MBC patient. "I'm glad we
have conferences like the MBCN Regional Conference here in New York. We
need to come together to discuss our feelings, needs, and ways to
constructively engage with the fact of cancer in our lives."
About Metastatic Breast Cancer
According to the American Cancer Society, MBC is defined as the spread
of a malignant tumor from its original site (the breast) to other parts of
the body. Patients with MBC need the support and recognition from the
public and the larger breast cancer community in their fight for treatments
to extend life as the search for a cure continues. According to the
American Cancer Society, 178,480 women will be diagnosed with breast cancer
in 2007. It is estimated that 150,000 women in the US are currently living
About Metastatic Breast Cancer Network
MBCN is a national independent advocacy group of and for people with
MBC. The organization intends to give those living with MBC a greater voice
in the breast cancer community. In 2004, a group of women from the New York
area with MBC, with guidance from Roz Kleban, MSW, Administrative
Supervisor of Social Services at Memorial Sloan-Kettering Cancer Center,
founded MBCN. MBCN is supported in part through charitable contributions
from many sources including Abraxis BioScience and AstraZeneca.
Date: Saturday, October 13, 2007
Location: NYU Medical Center, 401 East 30 Street, between 1st Avenue &
Sign-in: 9:30 AM, Program 10 AM - 4 PM
Those who are interested in additional information about the Conference
or in attending should visit http://www.mbcnetwork.org.
SOURCE Metastatic Breast Cancer Network